首页 | 本学科首页   官方微博 | 高级检索  
检索        

SHORT-TIME EFFECTS OF BRONCHIAL ARTERY INFUSION WITH CHEMICAL DRUGS FOR LUNG CANCER
引用本文:姚阳,潘跃银,李章钧,朱赤.SHORT-TIME EFFECTS OF BRONCHIAL ARTERY INFUSION WITH CHEMICAL DRUGS FOR LUNG CANCER[J].中国癌症研究,1995,7(2):153-156.
作者姓名:姚阳  潘跃银  李章钧  朱赤
作者单位:Yaoyang;Pan Yueyin(Cancer Research Institute,Affiliated Hospital,Anhui Medical Univereity,Hefei 230022)Lizhanvun;Zhu Chi(Department of Raduiology,Affiliated Hospital,Anhui Medical Univereity,Hefei 230022)
摘    要:SHORT-TIMEEFFECTSOFBRONCHIALARTERYINFUSIONWITHCHEMICALDRUGSFORLUNGCANCERYaoyang姚阳;PanYueyin潘跃银(CancerResearchInstitute,Affili...


Short-time effects of bronchial artery infusion with chemical drugs for lung cancer
Yang Yao,Yueyin Pan,Zhangjun Li,Chi Zhu.Short-time effects of bronchial artery infusion with chemical drugs for lung cancer[J].Chinese Journal of Cancer Research,1995,7(2):153-156.
Authors:Yang Yao  Yueyin Pan  Zhangjun Li  Chi Zhu
Institution:1. Cancer Research Institute, Affiliated Hospital, Anhui Medical University, 230022, Hefei
2. Department of Radiology, Affiliated Hospital, Anhui Medical University, 230022, Hefei
Abstract:Bronchial artery infusion (BAI) with chemical agents was performed in 41 patients with lung carcinoma up to 61 times, included 33 cases (51 times) primary lung carcinoma (PLC) and 8 cases (10 times) lung metastatic carcinoma (LMC). Short - time effects were valuable in 31 cases with PLC and 7 cases with LMC. Complete remission (CR) plus partial rimission (PR) ocurred in 14 cases (45.16%) among 31 patients with PLC and 1 case (14.28%) among 14 patients with LMC (P<0.01). CR plus PR was 10 cases (52.63%) among 19 patients with central type cancer (CTC) and 4 cases (33.33%) among 12 patients with perprephal type cancer (PTC) of PLC (P<0.05). CR plus PR in 15 squamous carcinomas (SC), 6 adenocarcinomas (AC) 2 small cell undifferentiated carcinomas (SCLC) and 8 histologically unclassfied carcinomas (HUC) were 8 (53.33%), 1 (50%), and3 (37.5%), respectively. The rate of CR plus PR in squamous carcinoma was higher than that in adenocarcinoma and histologically unclassified carcinoma (P<0.05). There was no remarkable difference in CR plus PR among stage II–III and IV patients with PLC, CAP and FMP protocol treatment. This study also investigated and analysed the side effects of 41 patients by BAI treatment.
Keywords:Lung carcinoma  Bronchial atery infusion  Short-time effect  
本文献已被 CNKI SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号